Cell and gene therapy manufacturing capabilities in Australia and New Zealand.

Autor: O'Sullivan GM; Research Ethics & Governance Office, Royal Prince Alfred Hospital (RPAH), Sydney Local Health District (SLHD), Sydney, Australia., Velickovic ZM; Department of Cell and Molecular Therapies, RPAH, SLHD, Sydney, Australia; School of Medicine, The University of Sydney, Sydney, Australia., Keir MW; Department of Cell and Molecular Therapies, RPAH, SLHD, Sydney, Australia., Macpherson JL; Department of Cell and Molecular Therapies, RPAH, SLHD, Sydney, Australia; School of Medicine, The University of Sydney, Sydney, Australia., Rasko JEJ; Department of Cell and Molecular Therapies, RPAH, SLHD, Sydney, Australia; School of Medicine, The University of Sydney, Sydney, Australia; Gene and Stem Cell Therapy Program, Centenary Institute, The University of Sydney, Sydney, Australia. Electronic address: j.rasko@centenary.org.au.

Publikováno v: Cytotherapy [Cytotherapy] 2019 Dec; Vol. 21 (12), pp. 1258-1273. Date of Electronic Publication: 2019 Dec 03.